vs
Side-by-side financial comparison of Pangaea Logistics Solutions Ltd. (PANL) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($311.4M vs $183.9M, roughly 1.7× Pangaea Logistics Solutions Ltd.). Bio-Techne runs the higher net margin — 16.4% vs 6.5%, a 9.9% gap on every dollar of revenue. On growth, Pangaea Logistics Solutions Ltd. posted the faster year-over-year revenue change (24.9% vs -1.5%). Over the past eight quarters, Pangaea Logistics Solutions Ltd.'s revenue compounded faster (32.5% CAGR vs 1.3%).
Pangaea Logistics Solutions Ltd. is a global dry bulk logistics and shipping service provider. It operates a modern fleet of dry bulk vessels to transport a wide range of commodities including grains, minerals, construction materials, and energy-related raw materials, serving industrial, agricultural, and energy sector clients across North America, Europe, and Asia with tailored end-to-end bulk cargo supply chain solutions.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
PANL vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $183.9M | $311.4M |
| Net Profit | $11.9M | $51.0M |
| Gross Margin | — | 66.9% |
| Operating Margin | 9.5% | 24.2% |
| Net Margin | 6.5% | 16.4% |
| Revenue YoY | 24.9% | -1.5% |
| Net Profit YoY | 40.9% | 126.0% |
| EPS (diluted) | $0.18 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $311.4M | ||
| Q4 25 | $183.9M | $295.9M | ||
| Q3 25 | $168.7M | — | ||
| Q2 25 | $156.7M | $317.0M | ||
| Q1 25 | $122.8M | $316.2M | ||
| Q4 24 | $147.2M | $297.0M | ||
| Q3 24 | $153.1M | $289.5M | ||
| Q2 24 | $131.5M | $306.1M |
| Q1 26 | — | $51.0M | ||
| Q4 25 | $11.9M | $38.0M | ||
| Q3 25 | $12.2M | — | ||
| Q2 25 | $-2.7M | $-17.7M | ||
| Q1 25 | $-2.0M | $22.6M | ||
| Q4 24 | $8.4M | $34.9M | ||
| Q3 24 | $5.1M | $33.6M | ||
| Q2 24 | $3.7M | $40.6M |
| Q1 26 | — | 66.9% | ||
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% |
| Q1 26 | — | 24.2% | ||
| Q4 25 | 9.5% | 18.4% | ||
| Q3 25 | 10.0% | — | ||
| Q2 25 | 2.3% | -7.5% | ||
| Q1 25 | 2.4% | 12.2% | ||
| Q4 24 | 10.1% | 16.0% | ||
| Q3 24 | 9.8% | 13.8% | ||
| Q2 24 | 5.8% | 15.0% |
| Q1 26 | — | 16.4% | ||
| Q4 25 | 6.5% | 12.8% | ||
| Q3 25 | 7.2% | — | ||
| Q2 25 | -1.8% | -5.6% | ||
| Q1 25 | -1.6% | 7.1% | ||
| Q4 24 | 5.7% | 11.7% | ||
| Q3 24 | 3.3% | 11.6% | ||
| Q2 24 | 2.8% | 13.3% |
| Q1 26 | — | $0.32 | ||
| Q4 25 | $0.18 | $0.24 | ||
| Q3 25 | $0.19 | — | ||
| Q2 25 | $-0.04 | $-0.11 | ||
| Q1 25 | $-0.03 | $0.14 | ||
| Q4 24 | $0.19 | $0.22 | ||
| Q3 24 | $0.11 | $0.21 | ||
| Q2 24 | $0.08 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $103.1M | $209.8M |
| Total DebtLower is stronger | $249.6M | — |
| Stockholders' EquityBook value | $429.3M | $2.1B |
| Total Assets | $928.1M | $2.6B |
| Debt / EquityLower = less leverage | 0.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $209.8M | ||
| Q4 25 | $103.1M | $172.9M | ||
| Q3 25 | $94.0M | — | ||
| Q2 25 | $59.3M | $162.2M | ||
| Q1 25 | $63.9M | $140.7M | ||
| Q4 24 | $86.8M | $177.5M | ||
| Q3 24 | $93.1M | $187.5M | ||
| Q2 24 | $77.9M | $152.9M |
| Q1 26 | — | — | ||
| Q4 25 | $249.6M | $260.0M | ||
| Q3 25 | $256.2M | — | ||
| Q2 25 | $244.7M | $346.0M | ||
| Q1 25 | $251.0M | $330.0M | ||
| Q4 24 | $257.2M | $300.0M | ||
| Q3 24 | $133.6M | $300.0M | ||
| Q2 24 | $90.5M | $319.0M |
| Q1 26 | — | $2.1B | ||
| Q4 25 | $429.3M | $2.0B | ||
| Q3 25 | $420.3M | — | ||
| Q2 25 | $414.4M | $1.9B | ||
| Q1 25 | $420.8M | $2.0B | ||
| Q4 24 | $427.8M | $2.1B | ||
| Q3 24 | $332.6M | $2.1B | ||
| Q2 24 | $331.5M | $2.1B |
| Q1 26 | — | $2.6B | ||
| Q4 25 | $928.1M | $2.5B | ||
| Q3 25 | $932.1M | — | ||
| Q2 25 | $916.0M | $2.6B | ||
| Q1 25 | $918.0M | $2.6B | ||
| Q4 24 | $936.5M | $2.7B | ||
| Q3 24 | $749.2M | $2.7B | ||
| Q2 24 | $692.9M | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | 0.58× | 0.13× | ||
| Q3 25 | 0.61× | — | ||
| Q2 25 | 0.59× | 0.18× | ||
| Q1 25 | 0.60× | 0.16× | ||
| Q4 24 | 0.60× | 0.14× | ||
| Q3 24 | 0.40× | 0.14× | ||
| Q2 24 | 0.27× | 0.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $15.1M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 1.27× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $15.1M | — | ||
| Q3 25 | $28.6M | — | ||
| Q2 25 | $14.4M | $98.2M | ||
| Q1 25 | $-4.4M | $41.1M | ||
| Q4 24 | $19.3M | $84.3M | ||
| Q3 24 | $28.5M | $63.9M | ||
| Q2 24 | $9.0M | $75.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $93.3M | ||
| Q1 25 | — | $31.0M | ||
| Q4 24 | — | $77.5M | ||
| Q3 24 | — | $54.7M | ||
| Q2 24 | — | $57.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 29.4% | ||
| Q1 25 | — | 9.8% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 18.9% | ||
| Q2 24 | — | 18.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | — | 3.2% | ||
| Q2 24 | — | 5.9% |
| Q1 26 | — | — | ||
| Q4 25 | 1.27× | — | ||
| Q3 25 | 2.34× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | 2.29× | 2.42× | ||
| Q3 24 | 5.57× | 1.90× | ||
| Q2 24 | 2.43× | 1.86× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PANL
| Voyage | $166.3M | 90% |
| Charter | $13.1M | 7% |
| Terminal Stevedore Revenue | $4.4M | 2% |
TECH
| Protein Sciences segment revenue | $226.2M | 73% |
| Diagnostics and Spatial Biology segment revenue | $85.6M | 27% |
| Other revenue (1) | $5.4M | 2% |
